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In different neuroblastorna ccl1 lines and transfected clones, an increasing plasma membrane redox activity umcl3tcs with amplification and 
enhanced expression of the N-rn~c oncogene. Furthermore, plasma membrane redox activity is partially inhibited by retinoic acid in ncurobhstoma 
cells with multiple copies of the N-rrryc oncogcnc but not in neuroblastoma cells with only one copy of this gene. 
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1. INTRODUCTlON 
Plasma membrane redox system (PMRS) activities 
have been found in every cell examined [l]. They can 
now be related to several vital functions, including the 
control of cell growth [2,3]. As a matter of fact, PMRS 
nctivities eem to be modified in transformed cells, as 
compared with those shown by normal untransformed 
cells [4,5]. 
Neuroblastoma is a common childhood solid tumor 
[6]. Amplification of the N-n?yc oncogene resulting in 
high N-q,+c expression is thought to be causally in- 
volved in the progression of neuroblnstoma toadvanced 
stages of malignancy [7]. 
Different neuroblastoma cell lines carrying different 
numbers of copy for the N-nzyc oncogene have been 
established. This fact makes neuroblastoma an optimal 
model system for the study of the changes in PMRS 
related to cell proliferation. 
In the present study, we have measured PMRS activ- 
ities of neuroblastoma cells containing different num- 
bers of N-/nJyc oncogcne, ranging from one copy in cells, 
corresponding to very initial stages in the evolution of 
malignancy, to more than 100 copies in highly malig- 
nant cells. The effects of retinoic acid and basic fibrob- 
last growth factor (b-FGF) are also shown. 
2. MATERIALS AND METHODS 
2. I . MfmiYrils 
Culture: dishes were from Falcon (Oxnard, CA, USA). RPMI-IG40 
medium, fetal calf serum, and antibiotics were from Ciibco (Eggcn- 
stein, Germany). All other reagents were I’rom Sigma (Dcisenhofcn, 
Germany). 
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2,2. Newolrlastomu cell hes 
Three well-established cell lines wcrc used: SH-EP (3 homogeneous 
SK-N-SH-derived subline), IMR-32, and Kelly, which carry I.25 and 
more than IO0 copies of N-rr?yc, respectively. In some experiments, 
two transfecteci clones derived from SH-EP cells were USL~: the 007 
clone, transfected with 3 control plnsmid; and the WAC?. clone, trans- 
I&ted with a plasmid carrying five caogenous copies of N-n?yc. Cell 
culture conditions and the establishment of the tran&ctedclonL~ have 
been described elsewhere [S]. 
2.3. Dlscontirurorls assay of PMRS activity 
Confluent cells were trypsinized. washed twice and suspended in 0.1 
M Tris-HCI (pH 7.4). Qunrtzcuvettes with 0.1 mM ascorbate ina final 
volume of 2 ml of 0.1 M Tris-HCI buffer were incubated, in the 
absence or presence of 5 x l(r cells, at 37OC under 5% CO, amos- 
phcrc. Absorbance at 265 nm was read at 5 min intervals for 45 min. 
Under the conditions used in the experimental procedure, the ftrst IO 
min allowed for equilibration, and afterwards the changes in absorb- 
anee remained linear throughout the rest of the experimental time; for 
this reason, the rates were calculated using the measurements in the 
range IO-45 min. The extinction coefficient was I4 rnM-’ . cm-‘. The 
decrease inthe autooxidation rate ofascorbatc in the prew’nce ofcells 
is a measure of semi-hydroascorbatc reduction by the cells [9]. 
2.4. Slrorr-wrtrt coo,trinuorti ossay of PMRS activiry 
Ascorbatc (0.1 mM) autooxidation i the absence or presence of IO5 
cells was continuously monitored for 5 min at 37% as previously 
described [IO]. 
3. RESULTS AND DISCUSSION 
Table I shows the results obtained in the discontinu- 
ous assay. All the data significantly differ from each 
other and it can very clearly be observed that an in- 
crease in N-myc amplification (that is, an increase in 
malignancy) perfectly correlates with an increase in 
PMRS activity. This result was confirmed in short-term 
continuous assays (see Table II). However, since SH- 
EP, lMR-32, and Kelly cells have difficrent origins, it 
would be possible to argue thai the different PMRS 
activity levels exhibited by these cells could be explained 
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Table I Table III 
Relative rates of axorbatc oxidation in the discontinuous ussay in the Inhibition of PMRS activity in two ncuroblastoma cell lines by reti- 
prcscncc of different ncuroblastoma cell lines noic acid and bFGF 
Cell line Copies of N-rn.rc Ascorbatc oxidation (%) 
‘None 100 r 2 
SH-EP I 542 I” 
IMR-32 2s 66 f II”“’ 
Kelly >I00 28 + t:l.b.’ 
Assays were carried out in the absence or presence of 5 x I OJ cells as 
described in Materials and Methods. Data are given as percentages, 
taking ascorbate autooxidation rate i!t the absence of cells as 100%. 
Figures are means t SD. for three different experiments. 
” Significant vs. control experiments without cells (P < 0.0 1). 
“Significant vs. experiments with SH-EP cclla (P c 0.01). 
E Significant vs. experiments with IMR-32 cells (P c 0.01). 
SH-EP culls IMR-32 cells 
Rctinoic acid (IO ,uM) -2f 5 50 -r- 3;’ 
bFGF (5 ng/ml) 262 II 23 -1- 20 
Continuous assays in the absence of presence of the different com- 
pounds were carried out with or without IO5 SH-EP or IMR-32 cells. 
Data are given as percentages of inhibition of the activities obtained 
in control experiments with cells and no compound added. The addi- 
tion of the compounds did not change ascorbate autooxidation rate 
significantly. Figures are means ? SD. for three different experiments. 
” Significant YS, cxpcrimcnts with SH-EP cells (P < 0.01). 
mainly by the differences in their origins more than by 
the degree of N-ln~~c amplification, To rule out this 
possibility, PMRS activity was also measured in two 
transfected clones derived from the homogeneous SH- 
EP subline [S]. Table II shows that once again the 
PMRS activity level correlates with N-~?Jx amplitica- 
tion. Since 007 and WAC2 clones have the same origin 
and they only differ in the expression of N-lnyc (that is, 
in their malignancy levels), it seems reasonable to con- 
clude that PMRS activity in neuroblastoma cells in- 
creases with amplification and enhanced expression of 
N-m~jc. The physiological and/or pathoiogical rele- 
vances of this correlation remains to be elucidated. 
Retinoids appear to induce variable effects on the 
proliferation of normal cells but they inhibit the growth 
of cells treated with a tumoral promoter, or spontane- 
ously transformed cells, and they prevent umor promo- 
tion [11,12]. On the other hand, bFGF behaves as a 
paracrine and autocrine growth factor to different 
tumor cells and it is one of the most potent of angio- 
genie factors known [13-151. The possible differential 
effects of retinoic acid and bFGF on PMRS activities 
were tested in two neuroblastoma cell lines (SH-EP, and 
IMR-32) by measuring the inhibition of the redox activ- 
ity in the presence of these compounds at frequently 
used concentrations [12,13,16]. As Table II1 shows, 10 
,uM retinoic acid induced significant inhibitions of 
PMRS activity in IMR-32 cells (those containing 25 
copies of N-lnyc) and had no effect on PMRS activity 
in SH-EP cells (those containing only one copy of N- 
,?zyc). These results are in agreement with the proposed 
anti-tumor activity of this compound [ 11 J, and they sup- 
port the idea that the observed correlation between 
tumor progression and PMRS activity should be physi- 
ologically and/or pathologically relevant. In contrast, 
bFGF produced similar levels of inhibition in both cell 
lines, irrespective of their malignancy !evels. 
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